Literature DB >> 8231212

Management of complications of Sideris transcatheter devices for atrial septal defect closure.

F A Arabia1, L J Rosado, T R Lloyd, G K Sethi.   

Abstract

Various devices that can be inserted transvenously to close an ostium secundum atrial septal defect are undergoing clinical trials. Although these are safe and effective in most instances, they may occasionally dislodge or fail to "button" properly, causing migration and embolization. We report two cases in which the occluder and counteroccluder of the Sideris device for transvenous atrial septal defect occlusion (Custom Medical Devices, Amarillo, Tex.) failed to "button" appropriately, migrating in the right atrium in one patient and embolizing to the pulmonary artery in the second patient. An emergency operation was required to retrieve the device and repair the atrial septal defect.

Entities:  

Mesh:

Year:  1993        PMID: 8231212

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  Closure of atrial septal defects by transcatheter devices.

Authors:  A G Magee; S A Qureshi
Journal:  Pediatr Cardiol       Date:  1997 Sep-Oct       Impact factor: 1.655

2.  Animal experimental implantation of an atrial septal defect occluder system.

Authors:  A Bloch Thomsen; M Schneider; U Baandrup; E V Stenbøg; J M Hasenkam; J P Bagger; G Hausdorf
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

3.  Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design.

Authors:  Ahmed A Khattab; Stephan Windecker; Peter Jüni; David Hildick-Smith; Dariusz Dudek; Henning R Andersen; Reda Ibrahim; Gerhard Schuler; Antony S Walton; Andreas Wahl; Heinrich P Mattle; Bernhard Meier
Journal:  Trials       Date:  2011-02-28       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.